685 related articles for article (PubMed ID: 31054052)
1. siRNA therapeutics: a clinical reality.
Saw PE; Song EW
Sci China Life Sci; 2020 Apr; 63(4):485-500. PubMed ID: 31054052
[TBL] [Abstract][Full Text] [Related]
2. Journey of siRNA: Clinical Developments and Targeted Delivery.
Nikam RR; Gore KR
Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
[TBL] [Abstract][Full Text] [Related]
3. Clinical advances of siRNA therapeutics.
Hu B; Weng Y; Xia XH; Liang XJ; Huang Y
J Gene Med; 2019 Jul; 21(7):e3097. PubMed ID: 31069898
[TBL] [Abstract][Full Text] [Related]
4. Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran.
Titze-de-Almeida SS; Brandão PRP; Faber I; Titze-de-Almeida R
Mol Diagn Ther; 2020 Feb; 24(1):49-59. PubMed ID: 31701435
[TBL] [Abstract][Full Text] [Related]
5. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
6. RNAi-based drug discovery and its application to therapeutics.
Hokaiwado N; Takeshita F; Banas A; Ochiya T
IDrugs; 2008 Apr; 11(4):274-8. PubMed ID: 18379962
[TBL] [Abstract][Full Text] [Related]
7. Patisiran: First Global Approval.
Hoy SM
Drugs; 2018 Oct; 78(15):1625-1631. PubMed ID: 30251172
[TBL] [Abstract][Full Text] [Related]
8. RNAi therapeutic and its innovative biotechnological evolution.
Weng Y; Xiao H; Zhang J; Liang XJ; Huang Y
Biotechnol Adv; 2019; 37(5):801-825. PubMed ID: 31034960
[TBL] [Abstract][Full Text] [Related]
9. Lipid nanoparticles for short interfering RNA delivery.
Leung AK; Tam YY; Cullis PR
Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
[TBL] [Abstract][Full Text] [Related]
10. Clinical Pharmacology of RNA Interference-Based Therapeutics: A Summary Based on Food and Drug Administration-Approved Small Interfering RNAs.
Jing X; Arya V; Reynolds KS; Rogers H
Drug Metab Dispos; 2023 Feb; 51(2):193-198. PubMed ID: 36332914
[TBL] [Abstract][Full Text] [Related]
11. Harnessing RNA interference to develop neonatal therapies: from Nobel Prize winning discovery to proof of concept clinical trials.
DeVincenzo JP
Early Hum Dev; 2009 Oct; 85(10 Suppl):S31-5. PubMed ID: 19833462
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrin-based siRNA delivery nanocarriers: a state-of-the-art review.
Chaturvedi K; Ganguly K; Kulkarni AR; Kulkarni VH; Nadagouda MN; Rudzinski WE; Aminabhavi TM
Expert Opin Drug Deliv; 2011 Nov; 8(11):1455-68. PubMed ID: 21867463
[TBL] [Abstract][Full Text] [Related]
13. In vivo application of RNA interference: from functional genomics to therapeutics.
Lu PY; Xie F; Woodle MC
Adv Genet; 2005; 54():117-42. PubMed ID: 16096010
[TBL] [Abstract][Full Text] [Related]
14. Development of siRNA Therapeutics for the Treatment of Liver Diseases.
Holm A; Løvendorf MB; Kauppinen S
Methods Mol Biol; 2021; 2282():57-75. PubMed ID: 33928570
[TBL] [Abstract][Full Text] [Related]
15. Development of new RNAi therapeutics.
Liu G; Wong-Staal F; Li QX
Histol Histopathol; 2007 Feb; 22(2):211-7. PubMed ID: 17149694
[TBL] [Abstract][Full Text] [Related]
16. Nanoengineered strategies for siRNA delivery: from target assessment to cancer therapeutic efficacy.
Mishra DK; Balekar N; Mishra PK
Drug Deliv Transl Res; 2017 Apr; 7(2):346-358. PubMed ID: 28050890
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
[TBL] [Abstract][Full Text] [Related]
18. Enhancing endosomal escape for nanoparticle mediated siRNA delivery.
Ma D
Nanoscale; 2014 Jun; 6(12):6415-25. PubMed ID: 24837409
[TBL] [Abstract][Full Text] [Related]
19. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
20. Imaging-guided delivery of RNAi for anticancer treatment.
Wang J; Mi P; Lin G; Wáng YX; Liu G; Chen X
Adv Drug Deliv Rev; 2016 Sep; 104():44-60. PubMed ID: 26805788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
